Impact of PeriCoronary Adipose Tissue Attenuation on Clinical Outcomes After Second Generation Drug-Eluting Stent Implantation

Impact of PeriCoronary Adipose Tissue Attenuation on Clinical Outcomes After Second Generation Drug-Eluting Stent Implantation - Impact of PeriCoronary Adipose Tissue Attenuation on Clinical Outcomes After Second Generation Drug-Eluting Stent Implantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051353

Enrollment

600

Registered

2023-08-01

Start date

2023-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing PCI for de novo native coronary lesions with second generation DES Patients who have undergone cCTA within 4 months prior to PCI

Exclusion criteria

Exclusion criteria: Patients diagnosed with ST elevation myocardial infarction Patients with inadequate evaluation of cCTA Patients with a history of coronary artery bypass grafting (CABG) Patients who have undergone PCI for chronic totally occluded lesions Patients undergoing PCI for left main coronary artery lesion

Design outcomes

Primary

Measure	Time frame
Patient-oriented Composite Endpoint(PoCE): composite endpoint of cardiac death, non-fatal myocardial infarction, and any revascularization.	—

Countries

Japan

Contacts

Public ContactHiromasa Otake

Kobe University Graduate School of Medicine Division of Cardiovascular Medicine, Department of Internal Medicine

hotake@med.kobe-u.ac.jp078-382-5111

Outcome results